Menu

Rainy Season Likely to Exacerbate Yemen’s Cholera Outbreak

Pregnant and lactating women are particularly vulnerable to the disease.

Aug 18, 2017
Shawna Williams

ISTOCKThe World Health Organization (WHO) announced this week that the number of recent cholera cases in Yemen has surpassed 500,000, and nearly 2,000 people there have died from the disease since the outbreak began in April.

Although the infection has a 99 percent survival rate if properly treated, the country’s healthcare structure has been “decimated” by war, the United Nations has stated. “A collapsing health system is struggling to cope, with more than half of all health facilities closed due to damage, destruction or lack of funds. Shortages in medicines and supplies are persistent and widespread and 30,000 critical health workers have not been paid salaries in nearly a year,” WHO notes.

See “Cholera Ripping Through Yemen”

The United Nations Population Fund had previously reported that pregnant and lactating women, especially those who are malnourished, are particularly at risk from the diarrheal disease. Also vulnerable are children and the elderly.

Despite widespread lack of access to health care and clean water, Deputy Representative of Unicef to Yemen, Sherin Varkey, tells Gulf News that interventions have succeeded in slowing the infection rate. But, he added, the upcoming rainy system is likely to reverse that trend.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.